Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omidria in Intraoperative Floppy Iris Syndrome
NCT02093689Phase 3
Key facts
- Status
- Terminated
- Start
- Feb 2014
- Primary completion
- Aug 2014
- Countries
- 2
- Sponsor
- Omeros Corporation
- Conditions
- intraoperative floppy iris syndrome (IFIS)
01
Overview
Phase 3, randomised, double-blind trial of phenylephrine + ketorolac in intraoperative floppy iris syndrome (IFIS) (3 arms), sponsored by Omeros Corporation. Primary endpoint: Change in Pupil Diameter. Started Feb 2014; status: terminated.
02
Design
3 arms- Study design
- RandomizedDouble-blind
Part 1 OMS302
OMS302 in BSS irrigation solution
Part 2 OMS302
OMS302 in BSS irrigation solution
Part 2 Placebo
Sodium citrate placebo in BSS irrigation solution
03
Endpoints
Primary
Change in Pupil Diameter
Beyond the preview
Go deeper on NCT02093689.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02093689.